About 84% of antibodies in plasma target non-RBD epitopes on SARS-CoV-2 spike protein, finds study

By | May 6, 2021
In a new study recently published in the journal Science, a team of researchers in the U.S. found that most of the antibodies circulating in the blood target areas of the viral spike protein outside the receptor-binding domain (RBD), the part of the spike that binds directly to human cell receptors.